Products classification
ABOUT US
Email:
sales@ruixibiotech.com
Tel.:
02988811435
Home > products > apis> dna-damage-dna-repa
Catalog name Description price
R-R-4928 5-ODMT cEt N-Bz A Phosphoramidite (Amidite) CAS No.1197033-19-4 5-ODMT cEt N-Bz A Phosphoramidite Amidite/CAS No.1197033-19-4 is a locked nucleic acid (LNA) analogue. 5-ODMT cEt N-Bz A Phosphoramidite Amidite possesses hybridization and mismatch discrimination attributes similar to those of LNA and shows resistance to exonuclease digestion. price>
R-R-4929 2-O,4-C-Methyleneadenosine CAS No.206055-70-1 2-O,4-C-Methyleneadenosine (LNA-A)/CAS No.206055-70-1 is a locked nucleic acid (LNA) and is also an adenosine analog. price>
R-R-4930 5-ODMT cEt G Phosphoramidite (Amidite) CAS No.945628-66-0 5-ODMT cEt G Phosphoramidite Amidite/CAS No.945628-66-0 is a potent nucleic acid analog. 5-ODMT cEt G Phosphoramidite Amidite shows excellent safety and antisense activity. price>
R-R-4931 9-(β-D-Xylofuranosyl)adenine CAS No.524-69-6 9-(β-D-Xylofuranosyl)adenine/CAS No.524-69-6 is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277). price>
R-R-4932 2-Fluoro-2-deoxy-ara-A(Bz)-3-phosphoramiditeCAS No.329187-86-2 2-Fluoro-2-deoxy-ara-A(Bz)-3-phosphoramidite/CAS No.329187-86-2 is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277). price>
R-R-4933 Nucleoside-Analog-1 CAS No.876707-99-2 Nucleoside-Analog-1/CAS No.876707-99-2 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups. price>
R-R-4934 AzddMeC CAS No.87190-79-2 AzddMeC (CS-92)/CAS No.87190-79-2 is an antiviral nucleoside analogue and a potent potent, selective and orally active HIV-1 reverse transcriptase and HIV-1 replication inhibitor. In HIV-1-infected human PBM cells and HIV-1-infected human macrophages, the EC50 values of AzddMeC are 9 nM and 6 nM, respectively. AzddMeC is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups. price>
R-R-4935 3-Deoxycytidine CAS No.7057-33-2 3-Deoxycytidine/4-Amino-1-((2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one/CAS No.7057-33-2 is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. price>
R-R-4936 Peldesine CAS No.133432-71-0 Peldesine (BCX 34)/CAS No.133432-71-0 is a potent, competitive, reversible and orally active purine nucleoside phosphorylase (PNP) inhibitor with IC50s of 36 nM, 5 nM, and 32 nM for human, rat, and mouse red blood cell (RBC) PNP, respectively. Peldesine is also a T-cell proliferation inhibitor with an IC50 of 800 nM. Peldesine has the potential for cutaneous T-cell lymphoma, psoriasis and HIV infection research.At equivalent molar concentrations, both the salt and free forms of a compound exhibit comparable biological activity. Nevertheless, the salt form (Peldesine dihydrochloride) usually boasts enhanced water solubility and stability. price>
R-R-4937 2-Deoxy-N3-methylcytidine hydriodide CAS No.79043-77-9 2-Deoxy-N3-methylcytidine hydriodide/CAS No.79043-77-9 is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. price>